Ticker League

EBITDA Margin for Johnson & Johnson (JNJ)

As of · Reported

Metric

TTM

30.3%

YoY change

+15.69pp

Trough year (1985)

17.0%

Peak year (2025)

43.6%

EBITDA Margin history chart for Johnson & Johnson (JNJ) from 1985 to 2025

Latest: 43.6%

EBITDA Margin change chart for Johnson & Johnson (JNJ) from 1985 to 2025

Latest: +15.69pp

EBITDA Margin history table for Johnson & Johnson (JNJ) from 1985 to 2025

  • 202543.6%+15.69pp
  • 202427.9%+0.52pp
  • 202327.4%-5.88pp
  • 202233.3%-0.71pp
  • 202134.0%+5.00pp
  • 202029.0%-1.07pp
  • 201930.0%-1.74pp
  • 201831.8%+0.07pp
  • 201731.7%-2.06pp
  • 201633.8%+0.25pp
  • 201533.5%-0.09pp
  • 201433.6%+5.50pp
  • 201328.1%+1.39pp
  • 201226.7%+1.99pp
  • 201124.7%-8.29pp
  • 201033.0%+2.36pp
  • 200930.7%-1.02pp
  • 200831.7%+4.91pp
  • 200726.8%-3.02pp
  • 200629.8%+0.25pp
  • 200529.5%-1.04pp
  • 200430.6%+0.15pp
  • 200330.4%-0.81pp
  • 200231.2%+1.88pp
  • 200129.4%+1.23pp
  • 200028.1%+1.37pp
  • 199926.8%+0.45pp
  • 199826.3%+1.17pp
  • 199725.1%+0.57pp
  • 199624.6%+1.39pp
  • 199523.2%+0.74pp
  • 199422.4%+1.14pp
  • 199321.3%+0.67pp
  • 199220.6%-0.72pp
  • 199121.3%-0.61pp
  • 199022.0%+0.69pp
  • 198921.3%+1.32pp
  • 198819.9%+0.41pp
  • 198719.5%+1.56pp
  • 198618.0%+0.99pp
  • 198517.0%—

EBITDA Margin values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Johnson & Johnson (JNJ)

According to Johnson & Johnson's latest reported financial statements, the company's latest reported EBITDA margin is 30.3%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Johnson & Johnson (JNJ) EBITDA margin totalled 43.59% – expanded 15.7 percentage points year-over-year.

The highest annual EBITDA margin of 43.59% was reported in 2025. The lowest in the available history was 16.98% in 1985.

Johnson & Johnson EBITDA Margin by Year

Johnson & Johnson EBITDA Margin 2025: 43.6%

2025's EBITDA margin for Johnson & Johnson came in at 43.59%, expanded 15.7 percentage points from 2024. This figure represents the highest annual value in the available history.

Johnson & Johnson EBITDA Margin 2024: 27.9%

Johnson & Johnson posted EBITDA margin of 27.90% in 2024, expanded 0.5 percentage points from 2023.

Johnson & Johnson EBITDA Margin 2023: 27.4%

In 2023, Johnson & Johnson reported EBITDA margin of 27.38%, contracted 5.9 percentage points from 2022.

Johnson & Johnson EBITDA Margin 2022: 33.3%

Johnson & Johnson EBITDA margin in 2022 was 33.26%, contracted 0.7 percentage points from 2021.

Johnson & Johnson EBITDA Margin 2021: 34.0%

Johnson & Johnson EBITDA margin in 2021 was 33.97%.

See more financial history for Johnson & Johnson (JNJ).

Sector peers by EBITDA Margin

Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest EBITDA margin

Frequently asked questions

Johnson & Johnson (JNJ) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview